» Articles » PMID: 22157874

Update on Corticotropin-releasing Factor Pharmacotherapy for Psychiatric Disorders: a Revisionist View

Overview
Date 2011 Dec 14
PMID 22157874
Citations 30
Authors
Affiliations
Soon will be listed here.
Citing Articles

Corticotropin releasing factor and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders.

Snyder A, Silberman Y Neuropharmacology. 2021; 201:108814.

PMID: 34624301 PMC: 8578398. DOI: 10.1016/j.neuropharm.2021.108814.


Chronic distress and the vulnerable host: a new target for HIV treatment and prevention?.

Contoreggi C, Chrousos G, Di Mascio M Neurobehav HIV Med. 2021; 7:53-75.

PMID: 34295195 PMC: 8293862. DOI: 10.2147/nbhiv.s86309.


Prefrontal corticotropin-releasing factor neurons impair sustained attention via distal transmitter release.

Hupalo S, Spencer R, Berridge C Eur J Neurosci. 2021; .

PMID: 33949025 PMC: 9215710. DOI: 10.1111/ejn.15260.


Biological intersection of sex, age, and environment in the corticotropin releasing factor (CRF) system and alcohol.

Agoglia A, Crofton E, Herman M Neuropharmacology. 2020; 170:108045.

PMID: 32217364 PMC: 7350391. DOI: 10.1016/j.neuropharm.2020.108045.


Amygdala, neuropeptides, and chronic pain-related affective behaviors.

Neugebauer V, Mazzitelli M, Cragg B, Ji G, Navratilova E, Porreca F Neuropharmacology. 2020; 170:108052.

PMID: 32188569 PMC: 7214122. DOI: 10.1016/j.neuropharm.2020.108052.


References
1.
Coric V, Feldman H, Oren D, Shekhar A, Pultz J, Dockens R . Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress Anxiety. 2010; 27(5):417-25. DOI: 10.1002/da.20695. View

2.
Boyson C, Miguel T, Quadros I, DeBold J, Miczek K . Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA. Psychopharmacology (Berl). 2011; 218(1):257-69. PMC: 3166547. DOI: 10.1007/s00213-011-2266-8. View

3.
Koob G, Zorrilla E . Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Curr Opin Investig Drugs. 2010; 11(1):63-71. PMC: 2812895. View

4.
Bale T, Vale W . CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol. 2004; 44:525-57. DOI: 10.1146/annurev.pharmtox.44.101802.121410. View

5.
Bailey J, Papadopoulos A, Diaper A, Phillips S, Schmidt M, van der Ark P . Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety. J Psychopharmacol. 2011; 25(9):1199-206. DOI: 10.1177/0269881111400650. View